PDF herunterladen
J Reconstr Microsurg 2023; 39(09): 715-726
DOI: 10.1055/a-2056-0729
Original Article

Trends of Autologous Free-Flap Breast Reconstruction and Safety during the Coronavirus Disease 2019 Pandemic

Nicholas A. Elmer 
1   Division of Plastic Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts
,
Valeria P. Bustos
1   Division of Plastic Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts
,
Anamika Veeramani
1   Division of Plastic Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts
,
Natalie Hassell
1   Division of Plastic Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts
,
Carly D. Comer
1   Division of Plastic Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts
,
Samuel M. Manstein
1   Division of Plastic Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts
,
Jacquelyn Kinney
1   Division of Plastic Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts
,
Bernard T. Lee
1   Division of Plastic Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts
,
Samuel J. Lin
1   Division of Plastic Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts
› Institutsangaben
› Weitere Informationen
    Lizenzen und Reprints

Abstract

Background Autologous free-flap breast reconstruction (ABR) is a valuable surgical option for patients following mastectomy. The coronavirus disease 2019 (COVID-19) pandemic has led to a myriad of factors that have affected access to care, hospital logistics, and postoperative outcomes. This study aims to identify differences in patient selection, hospital course and severity, and postoperative outcomes for patients who underwent ABR during and prior to the COVID-19 pandemic.

Methods Patients undergoing ABR from the American College of Surgeons National Surgical Quality Improvement Program 2019 to 2020 database were analyzed to compare sociodemographics, hospital course, and outcomes over the first postoperative month. Multivariable logistic regression was used to identify factors predictive of complications based on the operative year.

Results In total, 3,770 breast free flaps were stratified into two groups based on the timing of reconstruction (prepandemic and pandemic groups). Patients with a diagnosis of disseminated cancer were significantly less likely to undergo ABR during the COVID-19 pandemic. On univariate analysis, there were no significant differences in postoperative complications between the two groups. When controlling for potentially confounding sociodemographic and clinical risk factors, the COVID-19 group was significantly more likely to undergo reoperation compared with the prepandemic group (p < 0.05).

Conclusion When comparing outcomes for patients who underwent ABR prior to and during the COVID-19 pandemic, we found a significant increase in the odds of reoperation for those who had ABR during the pandemic. Debridement procedures and exploration for postoperative hemorrhage, thrombosis, or infection increased in the prepandemic group compared to the COVID-19 group. Notably, operative times decreased.

Keywords

autologous breast reconstruction - free-flap reconstruction - COVID-19


Publikationsverlauf

Eingereicht: 22. Juni 2022

Angenommen: 21. Februar 2023

Accepted Manuscript online:
16. März 2023

Artikel online veröffentlicht:
26. April 2023

© 2023. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 

  • References

  • 1 Kang JY, Michels A, Lyu F. et al. Rapidly measuring spatial accessibility of COVID-19 healthcare resources: a case study of Illinois, USA. Int J Health Geogr 2020; 19 (01) 36
    CrossrefPubMedGoogle Scholar
  • 2 Moynihan R, Sanders S, Michaleff ZA. et al. Impact of COVID-19 pandemic on utilisation of healthcare services: a systematic review. BMJ Open 2021; 11 (03) e045343
    CrossrefPubMedGoogle Scholar
  • 3 Bruce MK, Pfaff MJ, Anstadt EE, Losee JE, Goldstein JA. The impact of the COVID-19 pandemic on cleft care. Plast Reconstr Surg Glob Open 2021; 9 (04) e3587
    CrossrefPubMedGoogle Scholar
  • 4 Kutikov A, Weinberg DS, Edelman MJ, Horwitz EM, Uzzo RG, Fisher RI. A war on two fronts: cancer care in the time of COVID-19. Ann Intern Med 2020; 172 (11) 756-758
    CrossrefPubMedGoogle Scholar
  • 5 Hemal K, Boyd CJ, Bekisz JM, Salibian AA, Choi M, Karp NS. Breast reconstruction during the COVID-19 pandemic: a systematic review. Plast Reconstr Surg Glob Open 2021; 9 (09) e3852
    CrossrefPubMedGoogle Scholar
  • 6 Faulkner HR, Coopey SB, Liao EC, Specht M, Smith BL, Colwell AS. The safety of performing breast reconstruction during the COVID-19 pandemic. Breast Cancer 2022; 29 (02) 242-246
    CrossrefPubMedGoogle Scholar
  • 7 Sharp O, Masud D. Breast reconstruction with immediate autologous free tissue transfer in a peri-operative COVID-19 positive patient: a case report illustrating feasibility of aftercare. J Plast Reconstr Aesthet Surg 2021; 74 (03) 644-710
    CrossrefPubMedGoogle Scholar
  • 8 Ho W, Köhler G, Haywood RM, Rosich-Medina A, Masud D. Microsurgical autologous breast reconstruction in the midst of a pandemic: a single-unit COVID-19 experience. J Plast Reconstr Aesthet Surg 2022; 75 (01) 112-117
    CrossrefPubMedGoogle Scholar
  • 9 Vj G. A F, J D, et al. Immediate autologous free-flap breast reconstruction in the COVID-19 era can be safely performed. J Plast Reconstr Aesthet Surg 2021; 74 (09) 2392-2442
    CrossrefPubMedGoogle Scholar
  • 10 Balser J, Ryu J, Hood M, Kaplan G, Perlin J, Siegel B. Care systems COVID-19 impact assessment: lessons learned and compelling needs. NAM Perspect 2021; 2021: x
    PubMedGoogle Scholar
  • 11 American College Of Surgeons National Surgical Quality Improvement Program. ACS NSQIP | surgical quality improvement. Internet. Accessed February 20, 2022 at: http://site.acsnsqip.org
    PubMed
  • 12 Shiloach M, Frencher Jr SK, Steeger JE. et al. Toward robust information: data quality and inter-rater reliability in the American College of Surgeons National Surgical Quality Improvement Program. J Am Coll Surg 2010; 210 (01) 6-16
    CrossrefPubMedGoogle Scholar
  • 13 Henderson WG, Daley J. Design and statistical methodology of the National Surgical Quality Improvement Program: why is it what it is?. Am J Surg 2009; 198 (5, Suppl) S19-S27
    CrossrefPubMedGoogle Scholar
  • 14 Zhong T, Hu J, Bagher S. et al. A comparison of psychological response, body image, sexuality, and quality of life between immediate and delayed autologous tissue breast reconstruction: a prospective long-term outcome study. Plast Reconstr Surg 2016; 138 (04) 772-780
    CrossrefPubMedGoogle Scholar
  • 15 Billig J, Jagsi R, Qi J. et al. Should immediate autologous breast reconstruction be considered in women who require postmastectomy radiation therapy? A prospective analysis of Outcomes. Plast Reconstr Surg 2017; 139 (06) 1279-1288
    CrossrefPubMedGoogle Scholar
  • 16 Eltahir Y, Krabbe-Timmerman IS, Sadok N, Werker PMN, de Bock GH. Outcome of quality of life for women undergoing autologous versus alloplastic breast reconstruction following mastectomy: a systematic review and meta-analysis. Plast Reconstr Surg 2020; 145 (05) 1109-1123
    CrossrefPubMedGoogle Scholar
  • 17 Jagsi R, Jiang J, Momoh AO. et al. Trends and variation in use of breast reconstruction in patients with breast cancer undergoing mastectomy in the United States. J Clin Oncol 2014; 32 (09) 919-926
    CrossrefPubMedGoogle Scholar
  • 18 Lang JE, Summers DE, Cui H. et al. Trends in post-mastectomy reconstruction: a SEER database analysis. J Surg Oncol 2013; 108 (03) 163-168
    CrossrefPubMedGoogle Scholar
  • 19 Shippee TP, Kozhimannil KB, Rowan K, Virnig BA. Health insurance coverage and racial disparities in breast reconstruction after mastectomy. Womens Health Issues 2014; 24 (03) e261-e269
    CrossrefPubMedGoogle Scholar
  • 20 Sisco M, Du H, Warner JP, Howard MA, Winchester DP, Yao K. Have we expanded the equitable delivery of postmastectomy breast reconstruction in the new millennium? Evidence from the national cancer data base. J Am Coll Surg 2012; 215 (05) 658-666 , discussion 666
    CrossrefPubMedGoogle Scholar
  • 21 Oskar S, Nelson JA, Hicks MEV. et al. The impact of race on perioperative and patient-reported outcomes following autologous breast reconstruction. Plast Reconstr Surg 2022; 149 (01) 15-27
    CrossrefPubMedGoogle Scholar
  • 22 Bateni SB, Meyers FJ, Bold RJ, Canter RJ. Current perioperative outcomes for patients with disseminated cancer. J Surg Res 2015; 197 (01) 118-125
    CrossrefPubMedGoogle Scholar
  • 23 Shinan-Altman S, Levkovich I, Tavori G. Healthcare utilization among breast cancer patients during the COVID-19 outbreak. Palliat Support Care 2020; 18 (04) 385-391
    CrossrefPubMedGoogle Scholar
  • 24 Shankar A, Saini D, Roy S. et al. Cancer care delivery challenges amidst coronavirus disease—19 (COVID-19) outbreak: specific precautions for cancer patients and cancer care providers to prevent spread. Asian Pac J Cancer Prev 2020; 21 (03) 569-573
    CrossrefPubMedGoogle Scholar
  • 25 Di Felice G, Visci G, Teglia F, Angelini M, Boffetta P. Effect of cancer on outcome of COVID-19 patients: a systematic review and meta-analysis of studies of unvaccinated patients. [published online ahead of print, 2022 Feb 16] eLife 2022; 11: e74634
    CrossrefPubMedGoogle Scholar
  • 26 WHO. Report of the WHO-China Joint Mission on Coronavirus Disease 2019 (COVID-19). Geneva: WHO; 2020
    Google Scholar
  • 27 Chen J, Ray EC. The coronavirus (COVID-19) effect on public sentiments regarding elective plastic surgery in the United States. Plast Reconstr Surg Glob Open 2021; 9 (04) e3579
    CrossrefPubMedGoogle Scholar
  • 28 Baltodano PA, Schalet G, Rezak K. et al. Early discontinuation of breast free flap monitoring: a strategy driven by national data. Plast Reconstr Surg 2020; 146 (03) 258e-264e
    CrossrefPubMedGoogle Scholar
  • 29 Jallali N, Hunter JE, Henry FP. et al. The feasibility and safety of immediate breast reconstruction in the COVID-19 era. J Plast Reconstr Aesthet Surg 2020; 73 (11) 1917-1923
    CrossrefPubMedGoogle Scholar
  • 30 Uscher-Pines L, Sousa J, Jones M. et al. Telehealth use among safety-net organizations in California during the COVID-19 pandemic. JAMA 2021; 325 (11) 1106-1107
    CrossrefPubMedGoogle Scholar
  • 31 Funderburk CD, Batulis NS, Zelones JT. et al. Innovations in the plastic surgery care pathway: using telemedicine for clinical efficiency and patient satisfaction. Plast Reconstr Surg 2019; 144 (02) 507-516
    CrossrefPubMedGoogle Scholar
  • 32 Kiranantawat K, Sitpahul N, Taeprasartsit P. et al. The first Smartphone application for microsurgery monitoring: SilpaRamanitor. Plast Reconstr Surg 2014; 134 (01) 130-139
    CrossrefPubMedGoogle Scholar
  • 33 Arabi YM, Azoulay E, Al-Dorzi HM. et al. How the COVID-19 pandemic will change the future of critical care. Intensive Care Med 2021; 47 (03) 282-291
    CrossrefPubMedGoogle Scholar
  • 34 Chen KT, Mardini S, Chuang DC. et al. Timing of presentation of the first signs of vascular compromise dictates the salvage outcome of free flap transfers. Plast Reconstr Surg 2007; 120 (01) 187-195
    CrossrefPubMedGoogle Scholar
  • 35 Kroll SS, Schusterman MA, Reece GP. et al. Timing of pedicle thrombosis and flap loss after free-tissue transfer. Plast Reconstr Surg 1996; 98 (07) 1230-1233
    CrossrefPubMedGoogle Scholar
  • 36 Smit JM, Acosta R, Zeebregts CJ, Liss AG, Anniko M, Hartman EH. Early reintervention of compromised free flaps improves success rate. Microsurgery 2007; 27 (07) 612-616
    CrossrefPubMedGoogle Scholar
  • 37 Becker RC. COVID-19 update: Covid-19-associated coagulopathy. J Thromb Thrombolysis 2020; 50 (01) 54-67
    CrossrefPubMedGoogle Scholar
  • 38 Connors JM, Levy JH. COVID-19 and its implications for thrombosis and anticoagulation. Blood 2020; 135 (23) 2033-2040
    CrossrefPubMedGoogle Scholar
  • 39 Inouye D, Zhou S, Clark B, Swanson M, Chambers T. Two cases of impaired wound healing among patients with major head and neck free-flap reconstruction in the setting of COVID-19 infection. Cureus 2021; 13 (12) e20088
    PubMedGoogle Scholar
  • 40 Fleury CM, Chang BL, Slamin RP, Schwitzer JA, Kanuri A, Masden DL. Successful microsurgical reconstruction for limb salvage in a COVID-19-positive patient: a case report. J Reconstructive Microsurg Open 2021; 6 (01) e40-e44
    Artikel in Thieme ConnectPubMedGoogle Scholar
  • 41 Nassar AH, Maselli AM, Dowlatshahi AS. Microvascular free tissue transfer in the setting of COVID-19 associated coagulopathy: a case report. Orthoplastic Surgery 2021; 4: 20-22
    CrossrefPubMedGoogle Scholar
  • 42 Lhuaire M, Garrido I, Cladière-Nassif V, Dumaine V, Lantieri L. Reconstructive microsurgery emergency in a patient with COVID-19. Plast Reconstr Surg 2020; 146 (04) 523e-525e
    CrossrefPubMedGoogle Scholar
  • 43 Heiman AJ, Gabbireddy SR, Kotamarti VS, Ricci JA. A meta-analysis of autologous microsurgical breast reconstruction and timing of adjuvant radiation therapy. J Reconstr Microsurg 2021; 37 (04) 336-345
    Artikel in Thieme ConnectPubMedGoogle Scholar
  • 44 Eijkelboom AH, de Munck L, Vrancken Peeters MTFD. et al; NABON COVID-19 Consortium and the COVID and Cancer-NL Consortium. Impact of the COVID-19 pandemic on diagnosis, stage, and initial treatment of breast cancer in the Netherlands: a population-based study. J Hematol Oncol 2021; 14 (01) 64
    CrossrefPubMedGoogle Scholar
  • 45 Epelboym I, Gawlas I, Lee JA, Schrope B, Chabot JA, Allendorf JD. Limitations of ACS-NSQIP in reporting complications for patients undergoing pancreatectomy: underscoring the need for a pancreas-specific module. World J Surg 2014; 38 (06) 1461-1467
    CrossrefPubMedGoogle Scholar
  • 46 Sippel RS, Chen H. Limitations of the ACS NSQIP in thyroid surgery. Ann Surg Oncol 2011; 18 (13) 3529-3530
    CrossrefPubMedGoogle Scholar